SubsidieMeestersThe first non-clogging continuous flow reactor technology
Qfluidics aims to revolutionize flow chemistry by introducing a liquid tube technology that handles solids without clogging, enabling broader industrial applications and process intensification.
Projectdetails
Introduction
Flow chemistry represents a promising tool for the fine chemical and pharmaceutical industries to manufacture chemicals and drugs in a cheaper, greener, and safer way. However, current continuous flow systems present technical limitations, especially regarding handling solids and liquid viscous materials, which have hindered their adoption by the industry.
Current Limitations
Today, only 33% of the chemical processes can be conducted in continuous flow systems due to solid particles that clog the process.
Innovative Solution
At Qfluidics, we have developed a breakthrough technology that overcomes the limitations of conventional flow systems. Our proprietary technology, the liquid tube, allows for handling solids without clogging. This innovation paves the way toward a wide range of chemical processes and enables process intensification, making this technology ideal for industrial scale.
Future Plans
With the support of the EIC, we will industrialize our liquid tube flow reactors, bringing to the market modular solutions for research and industrial scale applications.
Financiële details & Tijdlijn
Financiële details
| Subsidiebedrag | € 2.499.343 |
| Totale projectbegroting | € 3.570.490 |
Tijdlijn
| Startdatum | 1-3-2024 |
| Einddatum | 28-2-2026 |
| Subsidiejaar | 2024 |
Partners & Locaties
Projectpartners
- QFLUIDICSpenvoerder
Land(en)
Vergelijkbare projecten binnen EIC Accelerator
| Project | Regeling | Bedrag | Jaar | Actie |
|---|---|---|---|---|
Development and validation of the first digital, clinical grade flow cytometry platform for enhanced diagnosis accuracy and sustainability in immunology and hemato oncologyMETAflow aims to revolutionize clinical flow cytometry by providing an automated, user-friendly platform for comprehensive data analysis, enhancing usability and robustness in diagnostics. | EIC Accelerator | € 2.499.579 | 2023 | Details |
Continuous Fiber Manufacturing for IndustryThe CFM4Industry project aims to revolutionize advanced composite manufacturing through automated Continuous Fiber Manufacturing technology for sustainable, cost-effective production across various industries. | EIC Accelerator | € 2.499.999 | 2024 | Details |
Development and validation of the first digital, clinical grade flow cytometry platform for enhanced diagnosis accuracy and sustainability in immunology and hemato oncology
METAflow aims to revolutionize clinical flow cytometry by providing an automated, user-friendly platform for comprehensive data analysis, enhancing usability and robustness in diagnostics.
Continuous Fiber Manufacturing for Industry
The CFM4Industry project aims to revolutionize advanced composite manufacturing through automated Continuous Fiber Manufacturing technology for sustainable, cost-effective production across various industries.
Vergelijkbare projecten uit andere regelingen
| Project | Regeling | Bedrag | Jaar | Actie |
|---|---|---|---|---|
Fibre-based plasmonic micro reactor for flow chemistryThe project aims to develop a novel light-driven chemical reactor using advanced technologies to enable sustainable production of chemicals, supporting the EU's goal of climate neutrality by 2050. | EIC Pathfinder | € 3.111.973 | 2023 | Details |
Liquid Crystals in Flow: A New Era in Sensing and DiagnosticsThis project aims to develop highly sensitive, label-free liquid crystal-based microfluidic sensors by investigating the effects of soft interfaces and chemical heterogeneity on flow dynamics and optical properties. | ERC Starting... | € 1.500.000 | 2022 | Details |
Commercial feasibility of a cell-free reactor setup for optimisation of complex enzymatic pathwaysThis project aims to commercialize a continuous stirred tank reactor for optimizing complex enzymatic pathways, enhancing production efficiency and establishing a viable commercialization strategy. | ERC Proof of... | € 150.000 | 2022 | Details |
Development & demonstration of low environmental impact innovation and optimization practices in pharma productionLIFE-GREENAPI aims to revolutionize API production in Europe by implementing flow-chemistry to enhance sustainability, reduce environmental impact, and support the pharmaceutical sector's decarbonization efforts. | LIFE Standar... | € 1.516.536 | 2023 | Details |
The first wide range flow sensor to unlock microfluidic cell analyses for preclinical studiesThe project aims to develop the GALILEO flow sensor to enhance microfluidic cell assays, improving therapeutic success rates and enabling earlier detection and treatment in drug development. | EIC Transition | € 1.667.500 | 2023 | Details |
Fibre-based plasmonic micro reactor for flow chemistry
The project aims to develop a novel light-driven chemical reactor using advanced technologies to enable sustainable production of chemicals, supporting the EU's goal of climate neutrality by 2050.
Liquid Crystals in Flow: A New Era in Sensing and Diagnostics
This project aims to develop highly sensitive, label-free liquid crystal-based microfluidic sensors by investigating the effects of soft interfaces and chemical heterogeneity on flow dynamics and optical properties.
Commercial feasibility of a cell-free reactor setup for optimisation of complex enzymatic pathways
This project aims to commercialize a continuous stirred tank reactor for optimizing complex enzymatic pathways, enhancing production efficiency and establishing a viable commercialization strategy.
Development & demonstration of low environmental impact innovation and optimization practices in pharma production
LIFE-GREENAPI aims to revolutionize API production in Europe by implementing flow-chemistry to enhance sustainability, reduce environmental impact, and support the pharmaceutical sector's decarbonization efforts.
The first wide range flow sensor to unlock microfluidic cell analyses for preclinical studies
The project aims to develop the GALILEO flow sensor to enhance microfluidic cell assays, improving therapeutic success rates and enabling earlier detection and treatment in drug development.